Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib

A 71-year-old woman with a four-year history of chronic lymphocytic leukemia (CLL) received ibrutinib as initial treatment due to progressive anemia and thrombocytopenia. Eleven months after the start of the treatments, although her cytopenia had ameliorated, she developed classic Hodgkin lymphoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshiishi, Megumi, Odate, Toru, Nakagawa, Yukie, Suzuki, Jun, Kumagai, Takuya, Kawashima, Ichiro, Yamamoto, Takeo, Nakajima, Kei, Tanaka, Masaru, Oishi, Naoki, Kondo, Tetuso, Kirito, Keita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580765/
https://www.ncbi.nlm.nih.gov/pubmed/33896865
http://dx.doi.org/10.2169/internalmedicine.6979-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580765/
https://www.ncbi.nlm.nih.gov/pubmed/33896865
http://dx.doi.org/10.2169/internalmedicine.6979-20

Ejemplares similares